In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'. The authors would like to make changes to the text and have replaced it to 'Hypersensitivity to ferric carboxymaltose or to any of the excipients of the study medication'. The authors have also made alterations to Fig. 1 . Corrected Fig. 1 and Table 2 are given below:
The original article can be found online at https://doi. org/10.1007/s13300-017-0330-z. Any person not willing to use adequate contraceptive precautions during the study and for up to 5 days after the last scheduled dose of study medication
